news
news

Pharma Sector Boosts API Investments to Reduce Import Reliance

India's pharmaceutical industry is making strategic investments in active pharmaceutical ingredients (APIs) and advanced therapies. This move aims to reduce reliance on imports and focus on high-value medicines. The shift is driven by the need for supply-chain resilience and enhanced manufacturing capabilities. Recent data shows strong growth in the domestic market and a rise in pharmaceutical exports, indicating a positive trend for local manufacturers. For more details, refer to the original publication.

Read the original article

© Neo Logistics. All Rights Reserved. Powered by ImpressAds